Abstract
BackgroundNovel therapies are urgently needed for ovarian cancer (OC), the fifth deadliest cancer in women. Preclinical work has shown that DNA methyltransferase inhibitors (DNMTis) can reverse the immunosuppressive tumor microenvironment...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have